Hiroshi Hirabayashi
Presidente en The Japan-India Association .
Origen de la red de primer grado Hiroshi Hirabayashi.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
Toyoko Inn Co., Ltd. (Tokyo)
 Toyoko Inn Co., Ltd. (Tokyo) Hotels/Resorts/Cruise linesConsumer Services Toyoko Inn Co., Ltd. is a private company based in Tokyo, Japan. The Japanese company provides corporate information and is the official corporate site for Toyoko Inn. ???????? ???????????????
4
| Private Company | Hotels/Resorts/Cruise lines | 4 |
NHK Promotions, Inc.
1
| Private Company | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Hiroshi Hirabayashi a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| TOKUSHU TOKAI PAPER CO., LTD. | Pulp & Paper | Director/Board Member Director/Board Member | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
| University of Tokyo | College/University | Graduate Degree Graduate Degree | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
| TOBU RAILWAY CO., LTD. | Railroads | Director/Board Member | |
| AMUSE INC. | Movies/Entertainment | Director/Board Member | |
| NITORI HOLDINGS CO., LTD. | Specialty Stores | Director/Board Member | |
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
| NISSHIN SEIFUN GROUP INC. | Agricultural Commodities/Milling | Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| KAWASAKI KISEN KAISHA, LTD. | Marine Shipping | Director/Board Member | |
| RICOH LEASING COMPANY, LTD. | Finance/Rental/Leasing | Director/Board Member | |
| ZENSHO HOLDINGS CO., LTD. | Restaurants | Director/Board Member | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
| RAKUTEN GROUP, INC. | Internet Retail | Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of San Diego | College/University | Masters Business Admin | |
| University of California San Diego | College/University | Undergraduate Degree | |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Compliance Officer | |
Sankyo Pharma GmbH
 Sankyo Pharma GmbH Medical DistributorsDistribution Services Part of Daiichi Sankyo Co., Ltd., Sankyo Pharma GmbH is a German pharmaceutical distribution company. The company is based in Munich, Germany. Jan van Ruymbeke has been the CEO of the company since 2012. | Medical Distributors | Chairman | |
| NIDEC CORPORATION | Electrical Products | Director/Board Member | |
Kashinomekai Foundation
 Kashinomekai Foundation Investment Trusts/Mutual FundsMiscellaneous Kashinomekai Foundation provides scholarship assistance. The company was founded on March 24, 1961 and is headquartered in Tokyo, Japan. | Investment Trusts/Mutual Funds | Director/Board Member | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELCUITY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| University of Connecticut | College/University | Corporate Officer/Principal | |
National Hospital Organization
 National Hospital Organization Hospital/Nursing ManagementHealth Services National Hospital Organization is an independent administrative agency under the umbrella of Ministry of Health, Labour, and Welfare of Japan that operates medical institutions. It provides medical and healthcare services. The firm also offers medical research and development, and healthcare engineers and medical technicians training. The organization was founded on April 4, 2004 and is headquartered in Tokyo, Japan. | Hospital/Nursing Management | Director/Board Member | |
| Stony Brook University | College/University | Undergraduate Degree | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
St. Luke's SRL Advanced Clinical Research Center, Inc.
 St. Luke's SRL Advanced Clinical Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services St. Luke's SRL Advanced Clinical Research Center, Inc. engages in specimen inspection, research support for clinical examinations, surveys, research and examinations related to treatment and prevention of disease and information provision activities. The company was founded on April 3, 2017 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| The Japan Medical Library Association | Chairman | ||
| Japan Hospital Association | Director/Board Member | ||
| St. Luke's International University | College/University | President | |
| St. Luke's International Hospital | President |
Estadísticas
Internacional
| Estados Unidos | 25 |
| Japón | 24 |
| Suiza | 2 |
| Francia | 2 |
| Alemania | 2 |
Sectorial
| Health Technology | 16 |
| Consumer Services | 13 |
| Finance | 6 |
| Health Services | 5 |
| Process Industries | 3 |
Operativa
| Director/Board Member | 75 |
| Corporate Officer/Principal | 24 |
| Independent Dir/Board Member | 24 |
| Chairman | 11 |
| President | 9 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Hiroshi Hirabayashi
- Conexiones Empresas
